Who
Vatnak Vat-Ho
Chief Business Officer
Company insider
Files Form 4 as: Chief Business Officer, Akari Therapeutics.
In numbers
- Trades disclosed
- 1
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 12 Oct 2026
- Last trade
- 12 Oct 2026
- Last filed
- 14 Oct 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Oct 2026filed 14 Oct 2026 | AKTX Akari Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —87,000 at $0.00 | filing |
News
Akari Therapeutics Appoints Accomplished Oncology and ADC Deal Executive Vatnak Vat-Ho as Chief Business Officer to Drive Strategic Growth and Partneringmanilatimes.net · 13 Oct 2026
1 headline in the last 90 days name Vatnak Vat-Ho; no company of theirs resolves to a name we track.
Sectors
No trade we could place in a sector.